Improving cancer diagnosis and care for HIV-related malignancies in Africa
Pathology Core
This study is working to improve how doctors diagnose cancer, especially in people with HIV in Malawi and South Africa, by creating a team that will make sure everyone has access to reliable pathology services, helping to ensure patients get the right treatment faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10891539 on NIH RePORTER |
What this research studies
This research focuses on enhancing tissue diagnosis for cancer care, particularly for HIV-related malignancies in Malawi and South Africa. It aims to establish a coordinated Pathology Core that will provide reliable access to pathology services through collaboration among various institutions. By developing a central pathology review process and forming working groups, the project seeks to improve the accuracy and efficiency of cancer diagnosis, which is crucial for effective treatment and research. The initiative addresses the logistical challenges faced in low- and middle-income countries to ensure better patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with HIV-related cancers in Malawi and South Africa.
Not a fit: Patients with cancers unrelated to HIV or those outside the geographic focus may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer diagnosis and treatment for patients affected by HIV-related malignancies.
How similar studies have performed: Previous initiatives have shown success in improving pathology services in similar low-resource settings, indicating the potential for impactful outcomes.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Fedoriw, Yuri — Univ of North Carolina Chapel Hill
- Study coordinator: Fedoriw, Yuri
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.